Bayer Submits NDA of Elinzanetant, Seeking Approval in the US for Vasomotor Symptoms Treatment
Shots: Bayer has submitted NDA of elinzanetant (dual NK-1 & 3 receptor antagon...
GSK Reports the US FDA’s Expanded Approval of Jemperli Plus Chemotherapy for Treating Endometrial Cancer
Shots: The US FDA has approved Jemperli (dostarlimab) + CT (carboplatin & pacl...
Innovent Reports the NMPA’s NDA Acceptance of Mazdutide to Treat Type 2 Diabetes
Shots: The NMPA has accepted 2nd NDA of mazdutide (a glucagon-like peptid...
Johnson & Johnson’s Darzalex Faspro Quadruplet Combination Gains the US FDA’s Approval to Treat Multiple Myeloma (MM)
Shots: The US FDA has approved Darzalex Faspro (daratumumab & hyaluronidase-fi...
Verastem Oncology’s Avutometinib Gains the US FDA’s Orphan Drug Designation to Treat Pancreatic Cancer
Shots: The US FDA has granted ODD to avutometinib + defactinib for treating pancre...
Roche’s Vabysmo (Faricimab) Receives the EC’s Approval to Treat Retinal Vein Occlusion (RVO)
Shots: The EC’s approval of Vabysmo for visual impairment caused by macular...
